Global and United States Postmenopausal Vaginal Atrophy Treatment Market Research by Company, Type & Application 2013-2025
- HEY2620709
- 91 Pages
- May 2018
- Pharmaceuticals
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
Market Segment as follows:
By Type
Creams
Tablets
Patches
Rings
By Application
Topical Estrogen
Systemic Estrogen
Non-hormonal Therapy
By Company
Allergan
Pfizer
Shionogi
Novo Nordisk
Teva Pharmaceutical
Bayer.
The main contents of the report including:
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Creams
1.1.2.2 Tablets
1.1.2.3 Patches
1.1.2.4 Rings
1.1.3 Market by Application
1.1.3.1 Topical Estrogen
1.1.3.2 Systemic Estrogen
1.1.3.3 Non-hormonal Therapy
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 Global and Regional Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 Global and Regional Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 Global and Regional Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 Regional Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Allergan
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Pfizer
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Shionogi
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Novo Nordisk
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Teva Pharmaceutical
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Bayer.
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
List Of Tables
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Allergan
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Shionogi
Table Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Table Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer.
List Of Figures
Figure Creams Market Size and CAGR 2013-2017 (Million USD)
Figure Creams Market Size and CAGR 2013-2017 (Volume)
Figure Creams Market Forecast and CAGR 2018-2025 (Million USD)
Figure Creams Market Forecast and CAGR 2018-2025 (Volume)
Figure Tablets Market Size and CAGR 2013-2017 (Million USD)
Figure Tablets Market Size and CAGR 2013-2017 (Volume)
Figure Tablets Market Forecast and CAGR 2018-2025 (Million USD)
Figure Tablets Market Forecast and CAGR 2018-2025 (Volume)
Figure Patches Market Size and CAGR 2013-2017 (Million USD)
Figure Patches Market Size and CAGR 2013-2017 (Volume)
Figure Patches Market Forecast and CAGR 2018-2025 (Million USD)
Figure Patches Market Forecast and CAGR 2018-2025 (Volume)
Figure Rings Market Size and CAGR 2013-2017 (Million USD)
Figure Rings Market Size and CAGR 2013-2017 (Volume)
Figure Rings Market Forecast and CAGR 2018-2025 (Million USD)
Figure Rings Market Forecast and CAGR 2018-2025 (Volume)
Figure Topical Estrogen Market Size and CAGR 2013-2017 (Million USD)
Figure Topical Estrogen Market Size and CAGR 2013-2017 (Volume)
Figure Topical Estrogen Market Forecast and CAGR 2018-2025 (Million USD)
Figure Topical Estrogen Market Forecast and CAGR 2018-2025 (Volume)
Figure Systemic Estrogen Market Size and CAGR 2013-2017 (Million USD)
Figure Systemic Estrogen Market Size and CAGR 2013-2017 (Volume)
Figure Systemic Estrogen Market Forecast and CAGR 2018-2025 (Million USD)
Figure Systemic Estrogen Market Forecast and CAGR 2018-2025 (Volume)
Figure Non-hormonal Therapy Market Size and CAGR 2013-2017 (Million USD)
Figure Non-hormonal Therapy Market Size and CAGR 2013-2017 (Volume)
Figure Non-hormonal Therapy Market Forecast and CAGR 2018-2025 (Million USD)
Figure Non-hormonal Therapy Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Postmenopausal Vaginal Atrophy Treatment Market Size and CAGR 2013-2017 (Million USD)
Figure Global Postmenopausal Vaginal Atrophy Treatment Market Size and CAGR 2013-2017 (Volume)
Figure Global Postmenopausal Vaginal Atrophy Treatment Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Postmenopausal Vaginal Atrophy Treatment Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Postmenopausal Vaginal Atrophy Treatment Market Size and CAGR 2013-2017 (Million USD)
Figure United States Postmenopausal Vaginal Atrophy Treatment Market Size and CAGR 2013-2017 (Volume)
Figure United States Postmenopausal Vaginal Atrophy Treatment Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Postmenopausal Vaginal Atrophy Treatment Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Postmenopausal Vaginal Atrophy Treatment SWOT List
Figure Healthcare & Medical Porter's Five Forces
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
